Diligent Pharma, Inc. — Form D
Diligent Pharma, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-16. The offering totals $9.3M, of which $3.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-02-16
- Form: D
- Accession: 0001965661-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $9.3M
- Amount sold: $3.5M
- Remaining: $5.8M
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2023-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473674
Issuer
- Name: Diligent Pharma, Inc.
- CIK: 0001965661
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 179 NASSAU STREET, PRINCETON, NJ, 08542
- Phone: 6096102815
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Patricia Leuchten | Executive Officer | Princeton, NJ |
More